908 Devices/$MASS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About 908 Devices
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
Ticker
$MASS
Sector
Digital Hardware
Primary listing
Employees
246
Headquarters
Website
908 Devices Metrics
BasicAdvanced
$232M
-
-$0.52
0.37
-
Price and volume
Market cap
$232M
Beta
0.37
52-week high
$8.06
52-week low
$1.81
Average daily volume
391K
Financial strength
Current ratio
4.977
Quick ratio
4.201
Long term debt to equity
2.687
Total debt to equity
0.291
Profitability
EBITDA (TTM)
-33.989
Gross margin (TTM)
48.49%
Net profit margin (TTM)
-26.10%
Operating margin (TTM)
-55.34%
Effective tax rate (TTM)
0.26%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-15.39%
Return on equity (TTM)
-53.40%
Valuation
Price to revenue (TTM)
3.198
Price to book
1.56
Price to tangible book (TTM)
2.07
Price to free cash flow (TTM)
-7.718
Free cash flow yield (TTM)
-12.96%
Free cash flow per share (TTM)
-0.832
Growth
Revenue change (TTM)
37.93%
Earnings per share change (TTM)
-54.63%
3-year revenue growth (CAGR)
13.92%
3-year earnings per share growth (CAGR)
-15.66%
What the Analysts think about 908 Devices
Analyst ratings (Buy, Hold, Sell) for 908 Devices stock.
908 Devices Financial Performance
Revenues and expenses
908 Devices Earnings Performance
Company profitability
908 Devices News
AllArticlesVideos
908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors
Business Wire·5 days ago
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025
Business Wire·3 weeks ago
Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for 908 Devices stock?
908 Devices (MASS) has a market cap of $232M as of August 09, 2025.
What is the P/E ratio for 908 Devices stock?
The price to earnings (P/E) ratio for 908 Devices (MASS) stock is 0 as of August 09, 2025.
Does 908 Devices stock pay dividends?
No, 908 Devices (MASS) stock does not pay dividends to its shareholders as of August 09, 2025.
When is the next 908 Devices dividend payment date?
908 Devices (MASS) stock does not pay dividends to its shareholders.
What is the beta indicator for 908 Devices?
908 Devices (MASS) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.